Agilent Acquires Cell Analysis Tools Developer ACEA Biosciences

Agilent Technologies said it has acquired ACEA Biosciences for $250 million cash, in a deal that expands the buyer’s offerings and presence in cell analysis technologies.San Diego-based ACEA—which dubs itself “The Cell Analysis Company—develops products used by researchers worldwide in drug discovery and development, toxicology, flow cytometry, cell analysis, safety pharmacology, disease studies, clinical diagnostics, and basic research.ACEA’s tools include xCELLige